Detalles de la búsqueda
1.
Effects of interleukin-6 signal inhibition on Treg subpopulations and association of Tregs with clinical outcomes in rheumatoid arthritis.
Rheumatology (Oxford)
; 2024 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38530780
2.
Anti-idiotype monoclonal antibodies against emicizumab enable accurate procoagulant and anticoagulant assays, irrespective of the test base, in the presence of emicizumab.
Haemophilia
; 29(1): 329-335, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36137299
3.
Heterogeneous coagulant potential of emicizumab in neonatal factor VIII-deficient plasma.
Pediatr Blood Cancer
; 69(7): e29731, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35441786
4.
Treatment with anti-IL-6 receptor antibody prevented increase in serum hepcidin levels and improved anemia in mice inoculated with IL-6-producing lung carcinoma cells.
BMC Cancer
; 16: 270, 2016 Apr 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27068103
5.
IL-6 receptor antibody treatment improves muscle weakness in experimental autoimmune myasthenia gravis mouse model.
Front Neurol
; 15: 1356300, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38751878
6.
Longitudinal monitoring of circulating immune cell phenotypes in anti-neutrophil cytoplasmic antibody-associated vasculitis.
Autoimmun Rev
; 22(3): 103271, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36627064
7.
Distinct gene signatures of monocytes and B cells in patients with giant cell arteritis: a longitudinal transcriptome analysis.
Arthritis Res Ther
; 25(1): 1, 2023 01 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36597161
8.
Predicted coagulation potential using an in vitro simulated model of emicizumab prophylaxis and immune tolerance induction therapy in hemophilia A patients with inhibitor.
Int J Hematol
; 113(6): 789-796, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33635530
9.
Ex Vivo Prediction of Comprehensive Coagulation Potential Using Simulated Blood Concentrations of Emicizumab in Patients with Acquired Hemophilia A.
Thromb Haemost
; 121(10): 1289-1298, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33641138
10.
An anti-factor IXa/factor X bispecific antibody, emicizumab, improves ex vivo coagulant potentials in plasma from patients with acquired hemophilia A.
J Thromb Haemost
; 18(4): 825-833, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31984625
11.
A modified thrombin generation assay to evaluate the plasma coagulation potential in the presence of emicizumab, the bispecific antibody to factors IXa/X.
Int J Hematol
; 112(5): 621-630, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32748217
12.
Emicizumab Improves Ex Vivo Clotting Function in Patients with Mild/Moderate Hemophilia A.
Thromb Haemost
; 120(6): 968-976, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32384547
13.
Characterization of Anti-Emicizumab Antibodies Using Repository Samples Obtained in Clinical Studies of Emicizumab Conducted in Japan.
TH Open
; 7(3): e241-e243, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37645671
14.
Emicizumab, A Bispecific Antibody to Factors IX/IXa and X/Xa, Does Not Interfere with Antithrombin or TFPI Activity In Vitro.
TH Open
; 2(1): e96-e103, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31249933
15.
The effect of frequency of C.E.R.A. administration on the contribution of dietary iron for erythropoiesis.
Int J Hematol
; 106(1): 60-70, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28293818
16.
Importance of Bevacizumab Maintenance Following Combination Chemotherapy in Human Non-small Cell Lung Cancer Xenograft Models.
Anticancer Res
; 37(2): 623-629, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28179309
17.
Visualization of 57Fe-Labeled Heme Isotopic Fine Structure and Localization of Regions of Erythroblast Maturation in Mouse Spleen by MALDI FTICR-MS Imaging.
J Am Soc Mass Spectrom
; 28(11): 2469-2475, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28819889
18.
Quantitative analysis of dietary iron utilization for erythropoiesis in response to body iron status.
Exp Hematol
; 44(6): 491-501, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26911670
19.
Reduction of a marker of oxidative stress with enhancement of iron utilization by erythropoiesis activation following epoetin beta pegol administration in iron-loaded db/db mice.
Int J Hematol
; 103(3): 262-73, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26739261
20.
Epoetin beta pegol (C.E.R.A.) promotes utilization of iron for erythropoiesis through intensive suppression of serum hepcidin levels in mice.
Int J Hematol
; 99(5): 561-9, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24623262